S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Biden's Plan to Confiscate Your Cash? (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Biden's Plan to Confiscate Your Cash? (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Biden's Plan to Confiscate Your Cash? (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
The Financial Day of Reckoning Has Begun (Ad)
Can You Guess Which EV Stock Is Beating Tesla ?
Closing prices for crude oil, gold and other commodities
Three Chinese corporate giants leaving NY stock exchange
Biden's Plan to Confiscate Your Cash? (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Pipeline break spills 45,000 gallons of diesel in Wyoming
Judge revives Obama-era ban on coal sales from federal lands
"Prepare for Five Years of Famine" (Ad)
NASDAQ:ADXS

Advaxis - ADXS Stock Forecast, Price & News

$3.38
-0.01 (-0.29%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.38
$3.78
50-Day Range
N/A
52-Week Range
$1.02
$51.60
Volume
1,496 shs
Average Volume
6,817 shs
Market Capitalization
$6.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Advaxis

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Advaxis in a research note on Wednesday. They issued a "sell" rating for the company.

Advaxis Stock Performance

Shares of NASDAQ:ADXS opened at $3.39 on Friday. Advaxis has a 1-year low of $1.02 and a 1-year high of $51.60.

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advaxis and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

See More Headlines
Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advaxis and its competitors with MarketBeat's FREE daily newsletter.

ADXS Company Calendar

Today
8/12/2022
Fiscal Year End
10/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADXS
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-17,860,000.00
Pretax Margin
-2,296.60%

Debt

Sales & Book Value

Annual Sales
$3.24 million
Book Value
$21.36 per share

Miscellaneous

Free Float
1,811,000
Market Cap
$6.14 million
Optionable
Not Optionable
Beta
2.22

Key Executives

  • Mr. Kenneth A. Berlin J.D. (Age 58)
    Pres & CEO
    Comp: $625.4k
  • Mr. Igor Gitelman CPA (Age 46)
    CPA, M.B.A., MBA, Chief Accounting Officer, Interim CFO & VP of Fin.
    Comp: $297.87k
  • Dr. Andres A. Gutierrez M.D. (Age 61)
    Ph.D., Exec. VP & Chief Medical Officer
    Comp: $472.03k













ADXS Stock - Frequently Asked Questions

How have ADXS shares performed in 2022?

Advaxis' stock was trading at $3.86 on January 1st, 2022. Since then, ADXS stock has decreased by 12.2% and is now trading at $3.39.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Advaxis own?

What is Advaxis' stock symbol?

Advaxis trades on the NASDAQ under the ticker symbol "ADXS."

How do I buy shares of Advaxis?

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Advaxis' stock price today?

One share of ADXS stock can currently be purchased for approximately $3.39.

How much money does Advaxis make?

Advaxis (NASDAQ:ADXS) has a market capitalization of $6.17 million and generates $3.24 million in revenue each year. The company earns $-17,860,000.00 in net income (profit) each year or ($6.70) on an earnings per share basis.

How can I contact Advaxis?

Advaxis' mailing address is 9 DEER PARK DRIVE SUITE K-1, MONMOUTH JUNCTION NJ, 08852. The official website for the company is www.advaxis.com. The company can be reached via phone at 609 452 9813, via email at tim@lifesciadvisors.com, or via fax at 609-452-9818.

This page (NASDAQ:ADXS) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.